Phase I dose escalation trial of weekly docetaxel plus irinotecan in patients with advanced cancer

Eric Bleickardt, Athanassios Argiris, Randy Rich, Kathi Blum, Anne McKeon, Harold Tara, Daniel Zelterman, Barbara Burtness, Marianne J. Davies, John R. Murren

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I dose escalation trial of weekly docetaxel plus irinotecan in patients with advanced cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences